Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Amarin, Z.O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amarin, Z.O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 4, 659-664, April 2003
© 2003 European Society of Human Reproduction and Embryology

Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome

An aggressive, but perhaps life-saving procedure

Z.O. Amarin1

Jordan University of Science and Technology, Irbid, Jordan

1 To whom correspondence should be addressed at: P.O.B 1572, Amman 11953, Jordan. E-mail: zoamarin{at}hotmail.com

Two case histories are described, in which protracted courses of severe ovarian hyperstimulation syndrome (OHSS) responded poorly to conservative treatment. Each patient underwent bilateral partial oophorectomy at 14 and 16 days respectively, post oocyte retrieval. Serum albumin levels returned to normal within three days of the operation in each case and the patients, one pregnant with twins, made a rapid recovery. This seemingly ‘aggressive’ procedure is proposed as a potentially useful treatment when faced with patients who are severely or critically affected with OHSS.

Key words: bilateral/IVF/OHSS/oophorectomy/partial


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome
Hum. Reprod. Update, April 2, 2008; (2008) dmn008v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Alvarez, I. Alonso-Muriel, G. Garcia, J. Crespo, J. Bellver, C. Simon, and A. Pellicer
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study
Hum. Reprod., December 1, 2007; 22(12): 3210 - 3214.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Gomez, M. Gonzalez-Izquierdo, R. C. Zimmermann, E. Novella-Maestre, I. Alonso-Muriel, J. Sanchez-Criado, J. Remohi, C. Simon, and A. Pellicer
Low-Dose Dopamine Agonist Administration Blocks Vascular Endothelial Growth Factor (VEGF)-Mediated Vascular Hyperpermeability without Altering VEGF Receptor 2-Dependent Luteal Angiogenesis in a Rat Ovarian Hyperstimulation Model
Endocrinology, November 1, 2006; 147(11): 5400 - 5411.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Revel, A. Safran, A. Benshushan, A. Shushan, N. Laufer, and A. Simon
In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: Case report
Hum. Reprod., July 1, 2004; 19(7): 1608 - 1611.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.